Advance Search

A Clinical Feature-Based Validation and Calibration for Diagnosing Hypertension and Cardiovascular Diseases: Integrative Review.: Validation and Calibration for Diagnosing Hypertension and Cardiovascular Disease

Validation and Calibration for Diagnosing Hypertension and Cardiovascular Disease

Nahla Abdulrahman
Department of Community Nursing, College of Nursing, Najran University, Najran, Saudi Arabia.
Abdelelah Hamed
Department of Medical Surgical , College of Nursing, Najran University, Najran, Saudi Arabia.
Nahid Elfaki
Department of Community Health Nursing, College of Nursing, Najran University, Najran, Saudi Arabia.
Amna Idris
Department of Medical Surgical , College of Nursing, Najran University, Najran, Saudi Arabia.
Wargaa Taha | Bio
Department of Nursing, College of Nursing, Najran University, Najran, Saudi Arabia.
Keywords:
Copyright and Licensing:

Copyright (c) 2025 Nahla Abdulrahman, Abdelelah Hamed, Nahid Elfaki, Amna Idris, Wargaa Taha (Author)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Share:
Crossref
Scopus
Google Scholar
Europe PMC

Abstract

Background and objective: Hypertension and Cardiovascular Diseases (CVD) are major global public health issues, leading to a large impact on illness and death rates. Prompt and precise identification of these diseases is essential for efficient management and avoidance of complication. This study aims to examine the significance of clinical characteristics in the diagnosis of cardiovascular diseases and hypertension. Identification and categorization of risk are crucial for prompt interventions and efficient management of these widespread and influential situations. The diagnostic techniques are based on clinical aspects, which include blood pressure measures, lipid profiles, family history, lifestyle choices, and comorbidities.

Methods: The review evaluates the validation and calibration of clinical characteristics, drawing from robust data obtained through extensive cohort studies, risk prediction models, and adherence to defined criteria. It examines the role of measuring blood pressure, lipid profiles, and lifestyle habits in efficiently identifying individuals at risk of developing hypertension and CVD. Additionally, the review explores the incorporation of technology innovations, such as wearable devices, mobile apps, and artificial intelligence, in improving the diagnostic process.

Results: This study shows that measuring blood pressure, lipid profiles, and lifestyle habits may efficiently detect individuals who are susceptible to develop hypertension and CVD. It is crucial to calibrate clinical characteristics in order to guarantee their precision and dependability in predicting the probability of hypertension and cardiovascular disease. This method entails enhancing risk assessment systems to include population-specific attributes and dynamic disease patterns. The incorporation of technology innovations, such as wearable devices, mobile apps, and artificial intelligence, has significantly improved the process of diagnosing clinical features, and the accuracy of predicting clinical parameters, making it easier to measure individualized risk and diagnose hypertension and cardiovascular disease at an early stage.

Conclusion: Incorporating verified clinical characteristics into risk assessment tools and prediction models, together with advancements in technology, has the capacity to enhance the early identification and individualized treatment of these illnesses. Ongoing research and innovation in this sector are crucial to improve diagnostic methods and increase the accuracy of clinical feature-based diagnosis for hypertension and cardiovascular disease.

PDF
PDF

Metrics

Metrics Loading ...

References

  1. Mensah GA, Roth GA, Fuster V. The global burden of cardiovascular diseases and risk factors: 2020 and beyond. ACollCard Found Washington, DC; 2019. P. 2529-32. doi.org/10.1016/j.jacc.2019.10.009
  2. Kjeldsen SE. Hypertension and cardiovascular risk: General aspects. Pharmres. 2018; 129:95-9.doi.org/10.1016/j.phrs.2017.11.003
  3. Birditt KS, Newton NJ, Cranford JA, Ryan LH. Stress and negative relationship quality among older couples: Implications for blood pressure. Journals of Geronto B Psycholo Sci and SocSci. 2016; 71(5):775-85. doi.org/10.1093/geronb/gbv023
  4. Reesink KD, Spronck B. Constitutive interpretation of arterial stiffness in clinical studies: a methodological review. AJPh -Heart and Circulatory Physiology. 2019; 316(3):H693-H709. doi.org/10.1152/ajpheart.00388.2018
  5. Magder SA. The highs and lows of blood pressure: toward meaningful clinical targets in patients with shock. Critcare Med. 2014; 42(5):1241-51. https://doi.org/10.1097/ccm.0000000000000324
  6. Cano J, Fácila L, Gracia-Baena JM, Zangróniz R, Alcaraz R, Rieta JJ. The relevance of calibration in machine learning-based hypertension risk assessment combining photoplethysmography and electrocardiography. Biosensors. 2022; 12(5):289. doi.org/10.3390/bios12050289
  7. Tocci G, Figliuzzi I, Presta V, Miceli F, Citoni B, Coluccia R, et al. Therapeutic approach to hypertension urgencies and emergencies during acute coronary syndrome. High Blood Press Cardiovasc Prev. 2018; 25:253-9. doi.org/10.1007/s40292-018-0275-y
  8. Whelton W. 2017 Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2017. doi:10.1001/jama.2017.18706
  9. Bird K, Chan G, Lu H, Greeff H, Allen J, Abbott D, et al. Assessment of hypertension using clinical electrocardiogram features: a first-ever review. Front. Med. 2020; 7:583331. doi.org/10.3389/fmed.2020.583331
  10. Hassing GJ, van der Wall HE, van Westen GJ, Kemme MJ, Adiyaman A, Elvan A, et al. Blood pressure-related electrocardiographic findings in healthy young individuals. Blood pres. 2020; 29(2):113-22. doi.org/10.1080/08037051.2019.1673149
  11. Palatini P. Role of elevated heart rate in the development of cardiovascular disease in hypertension. Hyper. 2011; 58(5):745-50. doi: 10.1161/HYPERTENSIONAHA.111.173104
  12. Voss A, Baumert M, Baier V, Stepan H, Walther T, Faber R. Autonomic cardiovascular control in pregnancies with abnormal uterine perfusion. A J Hyp. 2006; 19(3):306-12. doi.org/10.1016/j.amjhyper.2005.08.008
  13. Tison GH, Zhang J, Delling FN, Deo RC. Automated and interpretable patient ECG profiles for disease detection, tracking, and discovery. Circulation: Cardi Qual Outc. 2019; 12(9):e005289. doi.org/10.1161/CIRCOUTCOMES.118.005289
  14. Seccia TM, Caroccia B, Muiesan ML, Rossi GP. Atrial fibrillation and arterial hypertension: a common duet with dangerous consequences where the renin angiotensin-aldosterone system plays an important role. Int J Card. 2016; 206:71-6. doi.org/10.1016/j.ijcard.2016.01.007
  15. Nagueh SF. Left ventricular diastolic function: understanding pathophysiology, diagnosis, and prognosis with echocardiography. JACC: J Am Coll Cardiol Img. 2020; 13(1 Part 2):228-44. doi.org/10.1016/j.jcmg.2018.10.038
  16. Honda S, Asaumi Y, Yamane T, Nagai T, Miyagi T, Noguchi T, et al. Trends in the clinical and pathological characteristics of cardiac rupture in patients with acute myocardial infarction over 35 years. JAHA. 2014; 3(5):e000984. doi.org/10.1161/JAHA.114.000984
  17. Kotseva K, De Bacquer D, De Backer G, Rydén L, Jennings C, Gyberg V, et al. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions. Eur J Prev Card. 2016; 23(18):2007-18. doi.org/10.1177/2047487316667784
  18. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. Guidelines: Editor's choice: 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016; 37(29):2315. doi: 10.1093/eurheartj/ehw106
  19. Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020; 368. doi: 10.1136/bmj.m1091
  20. Zordoky BN, Robertson IM, Dyck JR. Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases. Jbbadis. 2015;1852(6):1155-77. doi: 10.1016/j.bbadis.2014.10.016
  21. Zhao H, Zhang X, Xu Y, Gao L, Ma Z, Sun Y, Wang W. Predicting the risk of hypertension based on several easy-to-collect risk factors: a machine learning method. Front. Public Health. 2021; 9:619429. doi: 10.3389/fpubh.2021.619429
  22. Chang W, Liu Y, Xiao Y, Yuan X, Xu X, Zhang S, Zhou S. A machine-learning-based prediction method for hypertension outcomes based on medical data. Diag. 2019; 9(4):178. doi: 10.3390/diagnostics9040178
  23. Tao S, Yu L, Yang D, Yao R, Zhang L, Huang L, et a;. Development and validation of a clinical prediction model for detecting coronary heart disease in middle-aged and elderly people: a diagnostic study. Eur J Med Res. 2023; 28(1):375. doi.org/10.1186/s40001-023-01233-0
  24. Wang C, Zhao Y, Jin B, Gan X, Liang B, Xiang Y, et al. Development and validation of a predictive model for coronary artery disease using machine learning. Front Cardiovasc Med. 2021; 8:614204. doi.org/10.3389/fcvm.2021.614204
  25. Negishi K, Yang H, Wang Y, Nolan MT, Negishi T, Pathan F, et al. Importance of calibration method in central blood pressure for cardiac structural abnormalities. AJH. 2016; 29(9):1070-6. doi.org/10.1093/ajh/hpw039
  26. Rustam F, Ishaq A, Munir K, Almutairi M, Aslam N, Ashraf I. Incorporating CNN Features for Optimizing Performance of Ensemble Classifier for Cardiovascular Disease Prediction. Diag. 2022; 12(6):1474. doi.org/10.3390/diagnostics12061474
  27. Chaikijurajai T, Laffin LJ, Tang WHW. Artificial intelligence and hypertension: recent advances and future outlook. AJH. 2020; 33(11):967-74. doi.org/10.1093/ajh/hpaa102
  28. Xu D, Liu R, Xu H, Zhang Z, Li W, Zhang Y, et al. Adoption of Two-Dimensional Ultrasound Gastrointestinal Filling Contrast on Artificial Intelligence Algorithm in Clinical Diagnosis of Gastric Cancer. Compu Math Med. 2022; 2022. doi.org/10.1155/2022/7385344
  29. Goodswen SJ, Barratt JL, Kennedy PJ, Kaufer A, Calarco L, Ellis JT. Machine learning and applications in microbiology. FEMS microbiology reviews. 2021; 45(5):fuab015. doi.org/10.1093/femsre/fuab015
  30. Zhu R, Jiang C, Wang X, Wang S, Zheng H, Tang H. Privacy-preserving construction of generalized linear mixed model for biomedical computation. Bioinfor. 2020; 36:128-35. doi.org/10.1093/bioinformatics/btaa478
  31. Santo K, Redfern J. Digital health innovations to improve cardiovascular disease care. Curr Atheroscler Rep. 2020; 22:1-10. doi.org/10.1007/s11883-020-00889-x
  32. Sun X, Yin Y, Yang Q, Huo T. Artificial intelligence in cardiovascular diseases: diagnostic and therapeutic perspectives. Eur J Med Res. 2023;28(1):242. doi.org/10.1186/s40001-023-01065-y
  33. Dankwa-Mullan I, Rivo M, Sepulveda M, Park Y, Snowdon J, Rhee K. Transforming diabetes care through artificial intelligence: the future is here. Pophealthmange. 2019; 22(3):229-42. doi.org/10.1089/pop.2018.0129
How to Cite
Abdulrahman, N., Hamed, A., Elfaki, N. ., Idris, A. ., & Taha, W. . (2025). A Clinical Feature-Based Validation and Calibration for Diagnosing Hypertension and Cardiovascular Diseases: Integrative Review.: Validation and Calibration for Diagnosing Hypertension and Cardiovascular Disease. Zanco Journal of Medical Sciences (Zanco J Med Sci), 403–413. https://doi.org/10.15218/zjms.2025.043

Send mail to Author

Send Cancel